MedTech & Diagnostics
Solventum Executive Compensation (FY25)
SOLV · Executive and director compensation, fiscal 2025 only
Data as of September 7, 2026Latest filing (8-K): May 20, 2026
184 figures on this page: 182 cited to the filing that reported them, 2 calculated from figures it prints. See the citations
Frequently asked questions
Answers drawn from the data on this page.
Who is Solventum's chief executive and what were they paid?
Bryan Hanson was paid $20,139,981 in total compensation as Chief Executive Officer for fiscal 2025.
What was Solventum's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 74.2% of votes cast for or against in favor at the meeting held May 15, 2026.
Which companies are in Solventum's peer group?
The disclosed peer group names Agilent Technologies, Inc., Align Technology, Inc., Avantor, Inc., Baxter International Inc. and Becton, Dickinson and Company, among others.
What is Solventum's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 245:1, against median employee compensation of $82,152.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Bryan Hanson Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Heather Knight Chief Commercial Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Wayde McMillan Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Christopher Barry Former EVP and Group President, Medical Surgical Departed during or after this year | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Marcela Kirberger Chief Corporate & Legal Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Amy Landucci Chief Information & Digital Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Amy L. Landucci | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Amy L. Landucci | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Bryan C. Hanson | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Bryan C. Hanson | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Christopher Barry | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Christopher Barry | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Heather Knight | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Marcela A. Kirberger | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Marcela A. Kirberger | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Wayde D. McMillan | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Wayde D. McMillan | RSU | ◇ | — | — | ◇ | — | — | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Wayde McMillan | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Marcela Kirberger | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Amy Landucci | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Bryan Hanson | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Christopher Barry | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Heather Knight | RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Marcela Kirberger
Chief Corporate & Legal Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
| Severance multiple | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
Amy Landucci
Chief Information & Digital Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
| Severance multiple | ◇ |
| Severance cash amount | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Carrie S. Cox Board chair | ◇ | ◇ | — | — | — | — | ◇ |
Glenn A. Eisenberg | ◇ | ◇ | — | — | — | — | ◇ |
Karen J. May | ◇ | ◇ | — | — | — | — | ◇ |
John H. Weiland | ◇ | ◇ | — | — | — | — | ◇ |
Susan D. DeVore | ◇ | ◇ | — | — | — | — | ◇ |
Elizabeth A. Mily | ◇ | ◇ | — | — | — | — | ◇ |
Carlos Albán | ◇ | ◇ | — | — | — | — | ◇ |
Shirley A. Edwards | ◇ | ◇ | — | — | — | — | ◇ |
Darryl L. Wilson | ◇ | ◇ | — | — | — | — | ◇ |
Amy A. Wendell | ◇ | ◇ | — | — | — | — | ◇ |
Dr. Bernard A. Harris, Jr | ◇ | ◇ | — | — | — | — | ◇ |
Bryan C. Hanson served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Audit committee chair | ◇ |
| Compensation committee chair | ◇ |
| Nominating and governance chair | ◇ |
Equity is delivered as restricted stock units.
Stock ownership guideline: 5x Annual Retainer
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Agilent Technologies, Inc. A
- Align Technology, Inc. ALGN
- Avantor, Inc. AVTR
- Baxter International Inc. BAX
- Becton, Dickinson and Company BDX
- Boston Scientific Corporation BSX
- Danaher Corporation DHR
- DENTSPLY SIRONA Inc. XRAY
- Edwards Lifesciences Corporation EW
- Fortive Corporation FTV
- GE HealthCare Technologies Inc. GEHC
- Hologic, Inc. HOLX
- Intuitive Surgical, Inc. ISRG
- IQVIA Holdings Inc. IQV
- Medtronic plc MDT
- ResMed Inc. RMD
- STERIS plc STE
- Stryker Corporation SYK
- The Cooper Companies, Inc. COO
- Zimmer Biomet Holdings, Inc. ZBH
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | May 15, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | April 30, 2025 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
What this page does not include
Everything above is a fact Solventum disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Solventum sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
184 figures on this page: 182 cited to the filing that reported them, 2 calculated from figures it prints.
182 cited to the filing
2 calculated from the filing
Documents cited
- 0001964738-26-000027
- 0001964738-26-0000172025 Director compensation · CEO pay ratio · Compensation Discussion and Analysis · Director Compensation · and 3 more sections
- 0001964738-25-000043
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Solventum executive compensation, FY2025.” https://intel.velarion.ai/comp/SOLV (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Solventum and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
MedTech & Diagnostics rankings
Peers Solventum discloses
The companies named in SOLV's own disclosed peer group.
Agilent Technologies, Inc.Align Technology, Inc.Avantor, Inc.Baxter International Inc.Becton, Dickinson and CompanyBoston Scientific CorporationDENTSPLY SIRONA Inc.Edwards Lifesciences CorporationGE HealthCare Technologies Inc.Hologic, Inc.Intuitive Surgical, Inc.IQVIA Holdings Inc.Medtronic plcResMed Inc.STERIS plcStryker CorporationThe Cooper Companies, Inc.Zimmer Biomet Holdings, Inc.
Terms on this page
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}